Thursday, May 30, 2019

Lupin#39;s Goa facility may face regulatory action, says USFDA

Lupin#39;s Goa facility may face regulatory action, says USFDA The company has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Goa facility between January 28 to February 8 as Official Action Indicated (OAI), Lupin said in a regulatory filing.

from Moneycontrol Business News http://bit.ly/2Z0UEHU
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...